BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24886852)

  • 1. Non-medical prescription opioid use, prescription opioid-related harms and public health in Canada: an update 5 years later.
    Fischer B; Gooch J; Goldman B; Kurdyak P; Rehm J
    Can J Public Health; 2014 Apr; 105(2):e146-9. PubMed ID: 24886852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review.
    Fischer B; Argento E
    Pain Physician; 2012 Jul; 15(3 Suppl):ES191-203. PubMed ID: 22786457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription Opioid Use, Harms and Interventions in Canada: A Review Update of New Developments and Findings since 2010.
    Murphy Y; Goldner EM; Fischer B
    Pain Physician; 2015; 18(4):E605-14. PubMed ID: 26218951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductions in non-medical prescription opioid use among adults in Ontario, Canada: are recent policy interventions working?
    Fischer B; Ialomiteanu A; Kurdyak P; Mann RE; Rehm J
    Subst Abuse Treat Prev Policy; 2013 Feb; 8():7. PubMed ID: 23406368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world?
    Fischer B; Keates A; Bühringer G; Reimer J; Rehm J
    Addiction; 2014 Feb; 109(2):177-81. PubMed ID: 23692335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harms of prescription opioid use in the United States.
    Imtiaz S; Shield KD; Fischer B; Rehm J
    Subst Abuse Treat Prev Policy; 2014 Oct; 9():43. PubMed ID: 25352167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription opioid prescribing, use/misuse, harms and treatment among Aboriginal people in Canada: a narrative review of available data and indicators.
    Russell C; Firestone M; Kelly L; Mushquash C; Fischer B
    Rural Remote Health; 2016; 16(4):3974. PubMed ID: 27871180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting the 'paradigm shift' in opioid use: Developments and implications 10 years later.
    Fischer B; Rehm J
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S199-S202. PubMed ID: 28334467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How many people in Canada use prescription opioids non-medically in general and street drug using populations?
    Popova S; Patra J; Mohapatra S; Fischer B; Rehm J
    Can J Public Health; 2009; 100(2):104-8. PubMed ID: 19839284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crude estimates of prescription opioid-related misuse and use disorder populations towards informing intervention system need in Canada.
    Fischer B; Varatharajan T; Shield K; Rehm J; Jones W
    Drug Alcohol Depend; 2018 Aug; 189():76-79. PubMed ID: 29886367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the prevalence of nonmedical prescription opioid use in the general Canadian population: methodological issues and questions.
    Fischer B; Nakamura N; Ialomiteanu A; Boak A; Rehm J
    Can J Psychiatry; 2010 Sep; 55(9):606-9. PubMed ID: 20840808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription opioid dispensing in Canada: an update on recent developments to 2018.
    Jones W; Vojtila L; Kurdyak P; Fischer B
    J Pharm Policy Pract; 2020; 13():68. PubMed ID: 33110608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing - exploratory analyses from Canada.
    Fischer B; Jones W; Tyndall M; Kurdyak P
    BMC Public Health; 2020 Jan; 20(1):143. PubMed ID: 32005211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-medical use of prescription opioids and public health in Canada: an urgent call for research and interventions development.
    Fischer B; Rehm J; Goldman B; Popova S
    Can J Public Health; 2008; 99(3):182-4. PubMed ID: 18615937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns, Changes, and Trends in Prescription Opioid Dispensing in Canada, 2005-2016.
    Fischer B; Jones W; Vojtila L; Kurdyak P
    Pain Physician; 2018 May; 21(3):219-228. PubMed ID: 29871366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An age-based analysis of nonmedical prescription opioid use among people who use illegal drugs in Vancouver, Canada.
    Cheng T; Small W; Dong H; Nosova E; Hayashi K; DeBeck K
    Subst Abuse Treat Prev Policy; 2018 Nov; 13(1):41. PubMed ID: 30482215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use and nonmedical use of prescription opioid analgesics in the general population of Canada and correlations with dispensing levels in 2009.
    Shield KD; Jones W; Rehm J; Fischer B
    Pain Res Manag; 2013; 18(2):69-74. PubMed ID: 23662288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canada's prescription opioid epidemic grows despite tamperproof pills.
    Dyer O
    BMJ; 2015 Sep; 351():h4725. PubMed ID: 26338104
    [No Abstract]   [Full Text] [Related]  

  • 19. The opioid mortality epidemic in North America: do we understand the supply side dynamics of this unprecedented crisis?
    Fischer B; Pang M; Jones W
    Subst Abuse Treat Prev Policy; 2020 Feb; 15(1):14. PubMed ID: 32066470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fentanyl use among street drug users in Toronto, Canada: behavioural dynamics and public health implications.
    Firestone M; Goldman B; Fischer B
    Int J Drug Policy; 2009 Jan; 20(1):90-2. PubMed ID: 18508256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.